Previous
Sierra Leone
Next

SERAC-Bangladesh
Shanghai Dahua is committed to advancing global family planning efforts, particularly the FP2020 goals, which aim to reach an additional 120 million women with family planning methods by 2020.
With a strong belief in the importance of women’s empowerment, Shanghai Dahua is dedicated to expanding access to high-quality, affordable contraceptives, including their WHO-prequalified implant product, Levoplant.
Commitments made to:
Shanghai Dahua is committed to expanding access to high-quality, effective, and affordable contraceptives that meet the needs of women, including those in hard-to-reach and vulnerable populations. Shanghai Dahua made a commitment to FP2020 countries to offer its WHO-prequalified implant product, Levoplant, at lower prices – making it readily available in FP2020 countries.
Shanghai Dahua Commitment Narratives
- Shanghai Dahua aims to ensure that cost is not a barrier to accessing effective contraception by offering Levoplant at lower prices, with a rate of US$7.50 per unit for orders above 300,000 units and US$8.00 per unit for orders below 300,000 units.
- Shanghai Dahua will register Levoplant in as many countries as possible, ensuring its widespread availability.
- Shanghai Dahua aims to make Levoplant even more affordable, contributing to increased accessibility for women worldwide.

Become an FP2030 Partner